Immune thrombocytopenia secondary to COVID-19 : a case report
Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social..
BACKGROUND: The SARS-CoV-2 virus, which emerged in late 2019 in Wuhan province, China, has shown a wide spectrum of manifestations, some of which it shares with some autoimmune disorders. Until now, the association of SARS-CoV-2 with immune thrombocytopenia (ITP) is poorly understood, since the mechanisms that explain the complex relationship between these two prothrombotic states are still unknown.
CLINICAL CASE: It is presented the case of a 66-year-old woman, with no chronic disease history, who arrived at the Emergency Department due to respiratory symptoms. It was carried out a polymerase chain reaction with reverse transcriptase, which was positive for SARS-CoV-2. Isolated thrombocytopenia was found in laboratory studies, which was protocolized by ruling out other causes and finally diagnosing ITP secondary to COVID-19. Intravenous steroids treatment was given observing a complete recovery in platelet levels.
CONCLUSIONS: Until now, the association of IPT and COVID-19 is unclear and presents challenges in treatment. Steroids continue to be the first choice with the indication to reduce their dose and duration to the minimum necessary. Other second-line treatments present more questions than answers in the context of this pandemic.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
Revista medica del Instituto Mexicano del Seguro Social - 58(2020), Supl 2 vom: 21. Sept., Seite S329-333 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Trombocitopenia inmune secundaria a COVID-19: reporte de un caso |
|---|
| Beteiligte Personen: |
Pérez-Martínez, Carlos Adrián [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 26.10.2021 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.24875/RMIMSS.M20000147 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332354288 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332354288 | ||
| 003 | DE-627 | ||
| 005 | 20231225215412.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.24875/RMIMSS.M20000147 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1107.xml |
| 035 | |a (DE-627)NLM332354288 | ||
| 035 | |a (NLM)34695348 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Pérez-Martínez, Carlos Adrián |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immune thrombocytopenia secondary to COVID-19 |b a case report |
| 246 | 3 | 3 | |a Trombocitopenia inmune secundaria a COVID-19: reporte de un caso |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 26.10.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright: © 2020 Revista Medica del Instituto Mexicano del Seguro Social. | ||
| 520 | |a BACKGROUND: The SARS-CoV-2 virus, which emerged in late 2019 in Wuhan province, China, has shown a wide spectrum of manifestations, some of which it shares with some autoimmune disorders. Until now, the association of SARS-CoV-2 with immune thrombocytopenia (ITP) is poorly understood, since the mechanisms that explain the complex relationship between these two prothrombotic states are still unknown | ||
| 520 | |a CLINICAL CASE: It is presented the case of a 66-year-old woman, with no chronic disease history, who arrived at the Emergency Department due to respiratory symptoms. It was carried out a polymerase chain reaction with reverse transcriptase, which was positive for SARS-CoV-2. Isolated thrombocytopenia was found in laboratory studies, which was protocolized by ruling out other causes and finally diagnosing ITP secondary to COVID-19. Intravenous steroids treatment was given observing a complete recovery in platelet levels | ||
| 520 | |a CONCLUSIONS: Until now, the association of IPT and COVID-19 is unclear and presents challenges in treatment. Steroids continue to be the first choice with the indication to reduce their dose and duration to the minimum necessary. Other second-line treatments present more questions than answers in the context of this pandemic | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus Infections | |
| 650 | 4 | |a Infecciones por Coronavirus | |
| 650 | 4 | |a Pandemias | |
| 650 | 4 | |a Pandemics | |
| 650 | 4 | |a Thrombocytopenia | |
| 650 | 4 | |a Trombocitopenia | |
| 700 | 1 | |a Casados-Rodríguez, Brandon Enrique |e verfasserin |4 aut | |
| 700 | 1 | |a Padilla-Santamaría, Fernando |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista medica del Instituto Mexicano del Seguro Social |d 2005 |g 58(2020), Supl 2 vom: 21. Sept., Seite S329-333 |w (DE-627)NLM156363798 |x 0443-5117 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2020 |g number:Supl 2 |g day:21 |g month:09 |g pages:S329-333 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.24875/RMIMSS.M20000147 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 58 |j 2020 |e Supl 2 |b 21 |c 09 |h S329-333 | ||